Zurich Cantonal Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9M | Buy |
|
|||||
|
2025
Q1 | $14.7M | Buy |
|
|||||
|
2024
Q4 | $13.1M | Buy |
|
|||||
|
2024
Q3 | $6.82M | Buy |
|
|||||
|
2024
Q2 | $7.77M | Buy |
|
|||||
|
2024
Q1 | $8.09M | Buy |
|
|||||
|
2023
Q4 | $7.53M | Buy |
|
|||||
|
2023
Q3 | $3.17M | Sell |
|
|||||
|
2023
Q2 | $3.16M | Buy |
|
|||||
|
2023
Q1 | $3.23M | Sell |
|
|||||
|
2022
Q4 | $3.45M | Sell |
|
|||||
|
2022
Q3 | $2.86M | Buy |
|
|||||
|
2022
Q2 | $2.47M | Sell |
|
|||||
|
2022
Q1 | $2.4M | Buy |
|
|||||
|
2021
Q4 | $2.6M | Sell |
|
|||||
|
2021
Q3 | $3.41M | Sell |
|
|||||
|
2021
Q2 | $3.83M | Buy |
|
|||||
|
2021
Q1 | $3.45M | Buy |
|
|||||
|
2020
Q4 | $3.36M | Buy |
|
|||||
|
2020
Q3 | $2.84M | Buy |
|
|||||
|
2020
Q2 | $3.58M | Sell |
|
|||||
|
2020
Q1 | $3.17M | Buy |
|
|||||
|
2019
Q4 | $2.95M | Hold |
|
|||||
|
2019
Q3 | $2.35M | Hold |
|
|||||
|
2019
Q2 | $2.99M | Sell |
|
|||||
|
2019
Q1 | $3.87M | Buy |
|
|||||
|
2018
Q4 | $3.58M | Buy |
|
|||||
|
2018
Q3 | $3.58M | Sell |
|
|||||
|
2018
Q2 | $3.54M | Hold |
|
|||||
|
2018
Q1 | $3.04M | Sell |
|
|||||
|
2017
Q4 | $3.37M | Sell |
|
|||||
|
2017
Q3 | $3.68M | Sell |
|
|||||
|
2017
Q2 | $3.62M | Sell |
|
|||||
|
2017
Q1 | $3.64M | Sell |
|
|||||
|
2016
Q4 | $3.56M | Buy |
|
|||||
|
2016
Q3 | $3.61M | Buy |
|
|||||
|
2016
Q2 | $1.67M | Hold |
|
|||||
|
2016
Q1 | $1.77M | Hold |
|
|||||
|
2015
Q4 | $2.25M | Buy |
|
|||||
|
2015
Q3 | $1.61M | Buy |
|
|||||
|
2015
Q2 | $1.95M | Sell |
|
|||||
|
2015
Q1 | $2.6M | Buy |
|
|||||
|
2014
Q4 | $1.39M | Buy |
|
|||||
|
2014
Q3 | $737K | Sell |
|
|||||
|
2014
Q2 | $3.7M | Buy |
|
|||||
|
2014
Q1 | $2.61M | Sell |
|
|||||
|
2013
Q4 | $3.69M | Sell |
|
|||||
|
2013
Q3 | $3.99M | Sell |
|
|||||
|
2013
Q2 | $4.76M | Buy |
|